Doctors Are Outsmarting Cancer With Tiny, High-Tech Tools

These trial drugs are 1/1000th the width of a human hair, gentle on the body, and remarkably affordable

Choosing the right drug to fight cancer is extremely difficult, and there’s a big price to pay for making the wrong choice. All cancer drugs have side effects—many weaken the body—and time spent taking the wrong drug is time that allows the cancer to grow and spread unchecked. Fortunately, chemical engineers have developed a method to combat this, sending nanoscale-sized particles packed with potential drug options inside patients’ tumors to test out which one will be the most effective, with the least amount of harm.

[quote position="left" is_quote="true"]A nanoparticle allows us to load miniscule amounts of medicine.[/quote]

Created by Avi Schroeder and his team of colleagues at the Technion-Israel Institute of Technology, this highly technical solution scales up our current system for treating cancer—which essentially boils down to a doctor making an educated guess about which drug might work best—then tests five or 10 drugs at once to find the best option with little to no consequences. To build these tiny trial drugs, Schroeder’s team first creates nanosized particles of each drug they’d like to screen. At 1/1,000th the width of a human hair, there’s no danger that they’ll have any major effect on the body.

“This is only possible when you use nanotechnology. A nanoparticle allows us to load miniscule amounts of medicine,” says Schroeder. But the nanoparticles aren’t useful to anyone when injected into the body all on their own: They are so small, they can’t be detected using any kind of chemical analysis tool that exists, which makes it nearly impossible to measure their impact. So Schroeder’s researchers came up with a novel solution, attaching each different nanoscale-scale drug to a unique strand of DNA. Generated by outside labs that build customized DNA sequences to order, they’re easy for doctors to spot in a genetic lineup and, thus, simple to analyze.

Once this process is complete, the nanoparticles—which are designed with an outer layer that looks like water to the immune system, keeping them from being attacked—are injected into a patient’s bloodstream. Because hungry tumors feed on blood vessels, the nanoparticles quickly and safely end up exactly where they need to go. Over a period of about 24 hours, they start killing (or not killing) cells inside the tumor. The drug that causes the most damage is determined to be the winner.

To track all that microscopic destruction, doctors must take a biopsy of a patient’s tumor about two days after initial injection. The tissue sample is disassembled into individual cells, some of which will be alive and some of which will be dead. Inside the dead cells—which have died because the medicine was effective—researchers locate those unique DNA strands that mark the treatment that killed them. Sometimes, more than one medicine proves effective, which makes the trial run even more useful.

“Let’s say we know a patient will have horrible side effects from one medicine and not the other and we know both will be effective. We can choose a medicine that will be preferable for the quality of life,” says Schroeder.

[quote position="right" is_quote="true"]We can choose a medicine that will be preferable for the quality of life.[/quote]

So far, this system has only been tested in mice, but in February, the technology is set to begin its transition from lab to clinic, where it will undergo trials on humans. Once it’s ready for prime time, Schroeder says the new testing technology will not only help save lives and increase the quality of those lives, but also should save quite a bit of money.

One current system for pretesting drugs, for example, requires growing a patient's tumor inside a mouse model, then giving the drugs to the mice to see if they fight the cancer. This process can cost tens of thousands of dollars (depending on how many drugs are tested) and can take many months. Schroeder estimates that Technion’s system could deliver results to patients within a week at a cost of about $5,000.

Narrowing down the safest and most affordable treatment “is a problem that doesn't have a current solution,” says Schroeder. “We’re really trying to do our best to save the patient and grant them a high quality of life.”

via Real Time with Bill Maher / YouTube and The Late Late Show with James Corden / YouTube

A controversial editorial on America's obesity epidemic and healthcare by comedian Bill Maher on his HBO show "Real Time" inspired a thoughtful, and funny, response by James Cordon. It also made for a great debate about healthcare that Americans are avoiding.

At the end of the September 6th episode of "Real Time, " Maher turned to the camera for his usual editorial and discussed how obesity is a huge part of the healthcare debate that no one is having.

"At Next Thursday's debate, one of the candidates has to say, 'The problem with our healthcare system is Americans eat shit and too much of it.' All the candidates will mention their health plans but no one will bring up the key factor: the citizens don't lift a finger to help," Maher said sternly.

Keep Reading Show less

There is no shortage of proposals from the, um, what's the word for it… huge, group of Democratic presidential candidates this year. But one may stand out from the pack as being not just bold but also necessary; during a CNN town hall about climate change Andrew Yang proposed a "green amendment" to the constitution.

Keep Reading Show less
Me Too Kit

The creator of the Me Too kit — an at home rape kit that has yet to hit the market — has come under fire as sexual assault advocates argue the kit is dangerous and misleading for women.

The kit is marketed as "the first ever at home kit for commercial use," according to the company's website. "Your experience. Your kit. Your story. Your life. Your choice. Every survivor has a story, every survivor has a voice." Customers will soon be able order one of the DIY kits in order to collect evidence "within the confines of the survivor's chosen place of safety" after an assault.

"With MeToo Kit, we are able to collect DNA samples and other tissues, which upon testing can provide the necessary time-sensitive evidence required in a court of law to identify a sexual predator's involvement with sexual assault," according to the website.

Keep Reading Show less

Villagers rejoice as they receive the first vaccines ever delivered via drone in the Congo

The area's topography makes transporting medicines a treacherous task.

Photo by Henry Sempangi Senyule

When we discuss barriers to healthcare in the developed world, affordability is commonly the biggest concern. But for some in the developing world, physical distance and topography can be the difference between life and death.

Widjifake, a hard-to-reach village in northwestern Democratic Republic of Congo (DRC) with a population of 6,500, struggles with having consistent access to healthcare supplies due to the Congo River and its winding tributaries.

It can take up to three hours for vehicles carrying supplies to reach the village.

Keep Reading Show less
via Keith Boykin / Twitter

Fox News and President Trump seem like they may be headed for a breakup. "Fox is a lot different than it used to be," Trump told reporters in August after one of the network's polls found him trailing for Democrats in the 2020 election.

"There's something going on at Fox, I'll tell you right now. And I'm not happy with it," he continued.

Some Fox anchors have hit back at the president over his criticisms. "Well, first of all, Mr. President, we don't work for you," Neil Cavuto said on the air. "I don't work for you. My job is to cover you, not fawn over you or rip you, just report on you."

Keep Reading Show less